Cargando…

Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience

Background. The E-MIOT (Extension-Myocardial Iron Overload in Thalassemia) project is an Italian Network assuring high-quality quantification of tissue iron overload by magnetic resonance imaging (MRI). We evaluated the impact of the COVID-19 pandemic on E-MIOT services. Methods. The activity of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meloni, Antonella, Pistoia, Laura, Lupi, Amalia, Righi, Riccardo, Vallone, Antonino, Missere, Massimiliano, Renne, Stefania, Fina, Priscilla, Riva, Ada, Gamberini, Maria Rita, Cecinati, Valerio, Sorrentino, Francesco, Rosso, Rosamaria, Messina, Giuseppe, Ricchi, Paolo, Positano, Vincenzo, Mavrogeni, Sophie, Quaia, Emilio, Cademartiri, Filippo, Pepe, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514849/ https://www.ncbi.nlm.nih.gov/pubmed/37736989 http://dx.doi.org/10.3390/tomography9050136

Ejemplares similares

The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study
por: Meloni, Antonella, et al.
Publicado: (2021)

Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy
por: Meloni, Antonella, et al.
Publicado: (2022)

Pancreatic T2* Magnetic Resonance Imaging for Prediction of Cardiac Arrhythmias in Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2023)

Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major
por: Meloni, Antonella, et al.
Publicado: (2023)

P1467: THE EMPLOYMENT OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY Β-THALASSEMIA: A MULTICENTER ANALYSIS FROM THE EXTENSION-MYOCARDIAL IRON OVERLOAD IN THALASSEMIA NETWORK (E-MIOT)
por: Raso, Simona, et al.
Publicado: (2023)

Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2022)

P1459: CHRONIC HEPATITIS C VIRUS INFECTION IS ASSOCIATED WITH AN INCREASED RISK OF CARDIAC COMPLICATIONS IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

P1515: IMPACT OF GENOTYPE ON PANCREATIC IRON OVERLOAD AND IMPAIRED GLUCOSE METABOLISM IN THALASSEMIA MAJOR
por: Meloni, A., et al.
Publicado: (2022)

P1514: MULTI-PARAMETRIC CARDIAC MAGNETIC RESONANCE FOR RISK PREDICTION OF HEART FAILURE DEATH IN THALASSEMIA MAJOR
por: Meloni, A., et al.
Publicado: (2022)

P1456: MULTIPARAMETRIC CMR AND CARDIAC COMPLICATIONS IN THALASSEMIA INTERMEDIA
por: Meloni, Antonella, et al.
Publicado: (2023)

Are the preferential patterns of myocardial iron overload preserved at the CMR follow-up?
por: Meloni, Antonella, et al.
Publicado: (2012)

P1454: CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance
por: Meloni, Antonella, et al.
Publicado: (2023)

mIoT Slice for 5G Systems: Design and Performance Evaluation
por: Trivisonno, Riccardo, et al.
Publicado: (2018)

Setting for “Normal” Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy
por: Spasiano, Anna, et al.
Publicado: (2021)

P1457: MOTION ABNORMALITIES IN THE LEFT VENTRICLE OF THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2023)

mIoT: Metamorphic IoT Platform for On-Demand Hardware Replacement in Large-Scaled IoT Applications
por: Lee, Dongkyu, et al.
Publicado: (2020)

An Identity Authentication Method of a MIoT Device Based on Radio Frequency (RF) Fingerprint Technology
por: Tian, Qiao, et al.
Publicado: (2020)

P1513: LOW VITAMIN D LEVELS ARE ASSOCIATED WITH INCREASED CARDIAC IRON UPTAKE IN THALASSEMIA MAJOR.
por: Meloni, A., et al.
Publicado: (2022)

Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
por: Makis, Alexandros, et al.
Publicado: (2013)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy
por: van Hattem, Jessica, et al.
Publicado: (2023)

HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives
por: Maffei, Laura, et al.
Publicado: (2020)

Updates in Hemoglobinopathies
por: Al-Tonbary, Youssef, et al.
Publicado: (2013)

P1512: HEART FAILURE IN THALASSEMIA MAJOR: TIME FOR NEW CARDIOVASCULAR MAGNETIC RESONCE MARKERS?
por: Meloni, A., et al.
Publicado: (2022)

Left Ventricle Detection from Cardiac Magnetic Resonance Relaxometry Images Using Visual Transformer
por: De Santi, Lisa Anita, et al.
Publicado: (2023)

Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications
por: Meloni, Antonella, et al.
Publicado: (2021)

Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2016)

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Gene Therapy of the Hemoglobinopathies
por: Kunz, Joachim B., et al.
Publicado: (2020)

Hemoglobinopathy and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Rare Combinational Hemoglobinopathies
por: Husan, Ammar, et al.
Publicado: (2022)

PB2533: FREQUENCY, PATTERN, AND CLINICAL CORRELATES OF RENAL IRON ACCUMULATION IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

PB2534: SARS-COV-2 IMMUNIZATION AFTER VACCINES IN PATIENTS WITH HEMOGLOBINOPATHY: A SINGLE CENTER EXPERIENCE
por: Duminuco, Andrea, et al.
Publicado: (2023)

Right Ventricular Volumes and Function normalized to body surface area, age and sex in a large cohort of well-treated Thalassemia Major without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2011)

Gene Therapy in Thalassemia and Hemoglobinopathies
por: Breda, Laura, et al.
Publicado: (2009)

New approaches for cholestasis in hemoglobinopathies
por: Dhiman, Pratibha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_408dinrg9r20gr44qv8jn3q50l